Tech Company Financing Transactions

Sorriso Pharmaceuticals Funding Round

Sorriso Pharmaceuticals secured a $31 million Series A funding round on 12/23/2021. Investors included Arix Bioscience, New Enterprise Associates and private investors.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

12230 El Camino Real 230
San Diego, CA 92130
USA

Phone

Undisclosed

Website

Email Address

Not Recorded

Overview

Sorriso Pharmaceuticals is a biotechnology company advancing a pipeline of disease-modifying antibodies for the treatment of inflammatory disease, including Crohn's disease and ulcerative colitis. The Sorriso platform generates potent antibodies that can be delivered orally and are designed to maintain activity throughout the intestinal system.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Ciara Kennedy

        

Browse more venture capital transactions:

Prev: 12/23/2021: TendedBar venture capital transaction
Next: 12/23/2021: Retool venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on tech company VC transactions. All VC database entries reported here are derived from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary